本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

7.84
-0.1000-1.26%
盘后7.70-0.1400-1.79%19:49 EDT
成交量:107.18万
成交额:832.90万
市值:7.75亿
市盈率:-4.51
高:7.90
开:7.87
低:7.65
收:7.94
52周最高:18.90
52周最低:6.66
股本:9,884.86万
流通股本:5,527.05万
量比:0.45
换手率:1.94%
股息:- -
股息率:- -
每股收益(TTM):-1.7400
每股收益(LYR):-1.7400
净资产收益率:-92.33%
总资产收益率:-33.04%
市净率:6.78
市盈率(LYR):-4.51

数据加载中...

2026/04/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/09

重要事件披露

Form 8-K - Current report
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/09/29

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

重要事件披露

Form 8-K - Current report
2025/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities